1017 related articles for article (PubMed ID: 15546503)
1. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage.
Yoshida K; Miki Y
Cancer Sci; 2004 Nov; 95(11):866-71. PubMed ID: 15546503
[TBL] [Abstract][Full Text] [Related]
2. The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.
Paul A; Paul S
Front Biosci (Landmark Ed); 2014 Jan; 19(4):605-18. PubMed ID: 24389207
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.
Welcsh PL; King MC
Hum Mol Genet; 2001 Apr; 10(7):705-13. PubMed ID: 11257103
[TBL] [Abstract][Full Text] [Related]
4. Cancer susceptibility and the functions of BRCA1 and BRCA2.
Venkitaraman AR
Cell; 2002 Jan; 108(2):171-82. PubMed ID: 11832208
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair.
O'Donovan PJ; Livingston DM
Carcinogenesis; 2010 Jun; 31(6):961-7. PubMed ID: 20400477
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 gene in breast cancer.
Rosen EM; Fan S; Pestell RG; Goldberg ID
J Cell Physiol; 2003 Jul; 196(1):19-41. PubMed ID: 12767038
[TBL] [Abstract][Full Text] [Related]
7.
Santana Dos Santos E; Lallemand F; Petitalot A; Caputo SM; Rouleau E
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481735
[TBL] [Abstract][Full Text] [Related]
8. The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?
Bertwistle D; Ashworth A
Breast Cancer Res; 1999; 1(1):41-7. PubMed ID: 11250682
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status.
Pooley KA; McGuffog L; Barrowdale D; Frost D; Ellis SD; Fineberg E; Platte R; Izatt L; Adlard J; Bardwell J; Brewer C; Cole T; Cook J; Davidson R; Donaldson A; Dorkins H; Douglas F; Eason J; Houghton C; Kennedy MJ; McCann E; Miedzybrodzka Z; Murray A; Porteous ME; Rogers MT; Side LE; Tischkowitz M; Walker L; Hodgson S; Eccles DM; Morrison PJ; Evans DG; Eeles RA; Antoniou AC; Easton DF; Dunning AM;
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1018-24. PubMed ID: 24642354
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and prostate cancer.
Rosen EM; Fan S; Goldberg ID
Cancer Invest; 2001; 19(4):396-412. PubMed ID: 11405179
[TBL] [Abstract][Full Text] [Related]
11. [Function of BRCA1 and BRCA2 genes associated with hereditary predisposition to breast cancer].
Jasińska A; Krzyzosiak WJ
Postepy Biochem; 2001; 47(2):146-59. PubMed ID: 11757317
[No Abstract] [Full Text] [Related]
12. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
13. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.
Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA
Breast Cancer Res Treat; 2003 Nov; 82(1):1-9. PubMed ID: 14672397
[TBL] [Abstract][Full Text] [Related]
14. PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
Zhang F; Ma J; Wu J; Ye L; Cai H; Xia B; Yu X
Curr Biol; 2009 Mar; 19(6):524-9. PubMed ID: 19268590
[TBL] [Abstract][Full Text] [Related]
15. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Villarreal-Garza C; Alvarez-Gómez RM; Pérez-Plasencia C; Herrera LA; Herzog J; Castillo D; Mohar A; Castro C; Gallardo LN; Gallardo D; Santibáñez M; Blazer KR; Weitzel JN
Cancer; 2015 Feb; 121(3):372-8. PubMed ID: 25236687
[TBL] [Abstract][Full Text] [Related]
16. The twists and turns in BRCA's path.
Couzin J
Science; 2003 Oct; 302(5645):591-3. PubMed ID: 14576418
[No Abstract] [Full Text] [Related]
17. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.
Bouwman P; Aly A; Escandell JM; Pieterse M; Bartkova J; van der Gulden H; Hiddingh S; Thanasoula M; Kulkarni A; Yang Q; Haffty BG; Tommiska J; Blomqvist C; Drapkin R; Adams DJ; Nevanlinna H; Bartek J; Tarsounas M; Ganesan S; Jonkers J
Nat Struct Mol Biol; 2010 Jun; 17(6):688-95. PubMed ID: 20453858
[TBL] [Abstract][Full Text] [Related]
18. Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients.
Rodríguez-Balada M; Roig B; Melé M; Albacar C; Serrano S; Salvat M; Querol M; Borràs J; Martorell L; Gumà J
Clin Biochem; 2020 Feb; 76():17-23. PubMed ID: 31786208
[TBL] [Abstract][Full Text] [Related]
19. [Molecular basis of breast cancer related to BRCA 1 and BRCA2 genes: characteristics and targeting therapy].
Levanat S; Cvok ML
Lijec Vjesn; 2010; 132(1-2):34-7. PubMed ID: 20359158
[TBL] [Abstract][Full Text] [Related]
20. Is TP53 dysfunction required for BRCA1-associated carcinogenesis?
Schuyer M; Berns EM
Mol Cell Endocrinol; 1999 Sep; 155(1-2):143-52. PubMed ID: 10580847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
